SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Blackstone Digital Infrastructure Trust entered into material definitive agreements in connection with its initial public offering on May 15, 2026, including a Registration Rights Agreement, Management Agreement, and a $1.0 billion senior secured revolving credit facility with expansion capacity to $4.0 billion.
View raw filing on EDGAR →Blackstone Digital Infrastructure Trust completed its initial public offering of 87.5 million shares at $20.00 per share on May 15, 2026, with underwriters exercising a full 30-day option for additional shares, resulting in gross proceeds of $2.0 billion.
View raw filing on EDGAR →The Board adopted the Blackstone Digital Infrastructure Trust Inc. Stock Incentive Plan on May 13, 2026, establishing a long-term incentive plan governing equity grants for officers and directors.
View raw filing on EDGAR →The company disclosed a material modification to rights of security holders, with the substance incorporated by reference from Item 5.03, relating to amendments affecting shareholder rights.
View raw filing on EDGAR →This is a clear Item 5.07 disclosure of shareholder vote results from Nucor's May 14, 2026 annual meeting. The filing reports voting outcomes for three proposals: election of eight directors (all passed with strong majorities), ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of named executive officer compensation. The detailed vote tallies and passage of all proposals are the core content of this 8-K section.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of Millrose Properties' annual stockholder meeting held on May 18, 2026. The filing presents detailed vote tallies for two proposals: election of five directors (Carlos A. Migoya, Patrick J. Bartels, Kathleen B. Lynch, Matthew B. Gorson, and M. Alison Mincey) and ratification of Deloitte & Touche LLP as independent auditor. All directors were elected and the auditor ratification passed by overwhelming margins, making this a material governance event that affects investor understanding of board composition and audit oversight.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure of shareholder vote results from Larimar Therapeutics' 2026 Annual Meeting held on May 19, 2026. The filing reports final voting tallies for six proposals: election of three Class III directors (Frank Thomas, Carole S. Ben-Maimon, M.D., and Joseph Truitt), advisory approval of named executive officer compensation, advisory frequency vote on compensation (one year preferred), ratification of PricewaterhouseCoopers LLP as independent auditor, approval of an amendment to increase authorized common shares from 115 million to 215 million, and approval of an adjournment. All proposals passed with substantial majorities. This is material as it confirms board composition and shareholder approval of key governance and capital structure matters.
View raw filing on EDGAR →Southwest Airlines entered into an Increase Joinder Agreement on May 19, 2026, amending its Term Loan Credit Agreement to add $1.0 billion in incremental term loans, bringing total outstanding principal to $1.5 billion. The new debt is secured by aircraft collateral and materially increases the company's leverage.
View raw filing on EDGAR →Sabre issued $150 million of exchangeable senior notes convertible into common stock at an initial exchange price of approximately $2.24 per share in a private placement relying on Section 4(a)(2) exemption. The exchangeable notes create significant dilution potential of 67–87 million shares upon exchange, with net proceeds used to repurchase $100 million of existing exchangeable notes and retire the remaining $50 million, representing a material capital structure transaction.
View raw filing on EDGAR →The Compensation Committee approved long-term incentive compensation arrangements for named executive officers, including performance restricted stock units (PRSUs) and restricted stock grants with dollar values ranging from $175,000 to $1,250,000 per executive and specified vesting schedules.
View raw filing on EDGAR →Shareholders voted at the Annual Meeting held on May 14, 2026, approving four proposals: election of nine directors, ratification of Deloitte & Touche LLP as independent auditor, re-approval of the 2024 Long-Term Incentive Plan, and an advisory vote on named executive officer compensation.
View raw filing on EDGAR →ACCO Brands held its Annual Meeting of stockholders with voting results on four proposals: election of nine directors, ratification of KPMG LLP as independent auditor, advisory vote on named executive officer compensation, and approval of an amendment to the 2022 Incentive Plan increasing available shares by 4,100,000 and eliminating fungible share counting ratios.
View raw filing on EDGAR →Wayne A. Stevens, President - Retail Banking of Trustmark Bank, notified the Boards of his intention to retire effective July 3, 2026. While the disclosure also mentions acceleration of vesting of restricted stock units, the principal disclosed action is the departure of a long-tenured executive officer (40 years of service, Executive Officer since 2009). The compensatory element (RSU acceleration) is secondary and incidental to the retirement announcement.
View raw filing on EDGAR →This is a clear disclosure of shareholder meeting voting results under Item 5.07. The filing reports results on three proposals: election of eleven directors (all elected), advisory vote on named executive officer compensation (passed), and ratification of auditor Plante & Moran, LLC (passed). These are routine but material governance matters that affect investor understanding of board composition and corporate oversight.
View raw filing on EDGAR →Cardiff Oncology filed a lawsuit against Nerviano Medical Sciences in U.S. District Court for the Southern District of California seeking injunctive relief and declaratory judgment regarding an alleged material breach of a license agreement for onvansertib. The dispute centers on patent inventorship obligations and continuation patent applications, with Cardiff disputing NMS's breach allegations. This is a material litigation event that would affect investor assessment of the company's ability to maintain its license rights and product development.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure of shareholder meeting results. The filing reports voting outcomes for five proposals at Dine Brands' 2026 Annual Meeting held May 14, 2026: election of nine directors, ratification of KPMG LLP as auditor, advisory approval of named executive officer compensation, advisory approval of special meeting rights at 25% threshold, and a stockholder proposal on 15% threshold special meeting rights. The detailed vote tallies (For, Against, Abstain, Broker Non-Votes) for each proposal are the core content of the disclosure.
View raw filing on EDGAR →Baker Hughes held its Annual Meeting of Stockholders on May 19, 2026, with shareholders voting on multiple matters including election of ten directors, advisory vote on executive compensation, ratification of KPMG LLP as auditor, and approval of the 2026 Long-Term Incentive Plan and amended ESPP. Detailed vote tallies for each matter are disclosed.
View raw filing on EDGAR →On May 19, 2026, Jaguar Health entered into three exchange agreements converting approximately $22.7 million in aggregate royalty interest reductions into 908 shares of Series Q Perpetual Preferred Stock, representing a material debt-for-equity restructuring that affects the Company's capital structure.
View raw filing on EDGAR →The filing discloses a press release issued on May 19, 2026 discussing financial results for the three months ended March 31, 2026. This is a quarterly earnings release furnished under Item 7.01 (Regulation FD Disclosure). Quarterly financial results are material to investors' assessment of the registrant's performance and are routinely disclosed via 8-K press releases.
View raw filing on EDGAR →EagleRock Land, LLC completed a registered public offering of 17.3 million Class A shares at $18.50 per share on May 13, 2026, with an additional 2.595 million shares issued via an exercised option, generating approximately $333.1 million in net proceeds. The offering also involved unregistered sales of equity securities under Section 4(a)(2) exemption through warrant exercise agreements and merger transactions resulting in issuance of Class A shares.
View raw filing on EDGAR →EagleRock Land, LLC completed a material reorganization transaction on May 15, 2026, in which multiple contributors transferred subsidiaries and assets to OpCo in exchange for OpCo Units and Class B shares, with assumption of the Predecessor Credit Facility. This restructuring reorganized the company's ownership and asset structure in connection with the public offering.
View raw filing on EDGAR →EagleRock Land, LLC appointed six new directors on May 13, 2026: Richard H. Coats as chairman and Raj Kumar, Jeff S. Lott, James C. Nelson, Stephanie Reed, and Michael Wallace as board members, expanding the Board from one director to seven members in connection with the public offering.
View raw filing on EDGAR →EagleRock Land, LLC disclosed a material modification to the rights of security holders on May 13, 2026, with substantive details incorporated by reference from Item 5.03; the specific nature of the modification cannot be determined from the available Item classifications.
View raw filing on EDGAR →STORE Capital completed issuance of $589 million in mortgage-backed notes through special purpose subsidiaries on May 19, 2026, pursuant to a Note Purchase Agreement entered May 14, 2026. The transaction involves material debt issuance to qualified institutional investors that will be used to repay existing indebtedness and fund growth, representing a material capital structure and financing event.
View raw filing on EDGAR →Gentherm held its annual meeting of shareholders on May 14, 2026, with voting results on four proposals: election of nine directors, advisory approval of named executive officer compensation, ratification of Ernst & Young LLP as independent auditor, and approval of an amendment to the 2023 Equity Incentive Plan increasing the share reserve by 1,700,000 shares.
View raw filing on EDGAR →Blackstone Mortgage Trust completed a $450 million offering of 6.250% Senior Secured Notes due 2031 under an indenture dated May 19, 2026. The company intends to use proceeds for general corporate purposes including paying down existing secured indebtedness.
View raw filing on EDGAR →Hancock Whitney Corporation entered into an Agreement and Plan of Merger on May 15, 2026, with OFB Bancshares, Inc., providing for a multi-step merger transaction whereby OFB Bancshares will ultimately merge into Hancock Whitney, followed by a bank-level merger of One Florida Bank into Hancock Whitney Bank. The transaction involves a cash consideration of $29.273 per share and is subject to customary regulatory approvals and shareholder vote. This is a material acquisition/merger activity requiring Item 1.01 disclosure.
View raw filing on EDGAR →Michael W. Bonney was appointed as Chair of the Board effective May 16, 2026. Mr. Bonney brings extensive executive and board leadership experience from prior CEO roles at Cubist Pharmaceuticals and Kaleido Biosciences, and this senior governance appointment is material to investors assessing the company's strategic direction.
View raw filing on EDGAR →The Company discloses that it remains unable to file its Form 10-Q due to "accounting adjustments required by the Company and its auditors in response to SEC comments on the Annual Report on Form 10-K for the financial year ended December 31, 2024." This indicates SEC-driven accounting corrections that cascade through interrelated financial figures in prior and current reports, a hallmark of restatement activity. While the filing does not explicitly use the word "restatement," the disclosure of required accounting adjustments to prior-year financials that prevent current-period filing is material and consistent with restatement disclosure patterns.
View raw filing on EDGAR →The Compensation Committee approved an increase in compensation for Michael W. West, the Chief Operating Officer, effective March 29, 2026, establishing his fiscal 2027 compensation package: base salary of $425,000, target performance-based cash incentive of 40% of base salary, and target long-term equity incentive of 65% of base salary. This is a direct disclosure of compensatory arrangements for a named executive officer under Item 5.02(e).
View raw filing on EDGAR →The filing discloses entry into an amendment to a Business Combination Agreement dated May 15, 2026, between Plum IV, Merger Sub, and Controlled Thermal Resources Holdings Inc. The amendment extends key deadlines for financial statement delivery, antitrust filings, and material consents. This is a material acquisition/change of control transaction involving a SPAC merger, clearly falling under Item 1.01 (Entry into a Material Definitive Agreement) and the ma_activity event type.
View raw filing on EDGAR →The filing discloses a shareholder letter and corporate update issued on May 18, 2026, but the Item 8.01 text itself provides no substantive detail about the content or nature of the update. Without access to Exhibit 99.1, the specific event cannot be precisely classified. Given that a formal shareholder letter and corporate update warrant 8-K disclosure, the event is presumed material, but the lack of descriptive language in the Item text prevents confident assignment to a more specific category.
View raw filing on EDGAR →The filing discloses a press release issued on May 13, 2026 announcing financial results for the quarter ended March 31, 2026, with an earnings call conducted on May 15, 2026. This is a standard quarterly earnings release disclosure under Item 2.02, which is material to investors as it provides the registrant's financial performance for the period.
View raw filing on EDGAR →Amesite Inc. announced securing a major new enterprise customer with a 2,700-patient census, described as "its largest deployment to date and a major milestone in validating its enterprise strategy." While this is a significant business development, it does not fit neatly into the standard event taxonomy (not an earnings release, M&A activity, or other defined categories). The disclosure is material to investors as it demonstrates validation of the company's enterprise strategy and represents a substantial customer win, but the event type is best classified as other_material given the absence of a more specific category.
View raw filing on EDGAR →InMed Pharmaceuticals entered into a definitive merger agreement with Mentari Therapeutics on May 19, 2026, whereby Mentari shareholders will receive approximately 98.49% of the combined company post-closing. The transaction contemplates a $125 million equity valuation for Mentari and involves a two-step merger structure with concurrent $150 million financing, constituting a material change of control requiring shareholder approval and SEC registration.
View raw filing on EDGAR →The filing discloses completion of a material acquisition (the "Merger") of Corvex Legacy Holdings, Inc. by Movano Inc. (now renamed Corvex, Inc.) on March 19, 2026, pursuant to an Amended and Restated Merger Agreement. Although Item 2.02 typically covers financial results, the substance of this disclosure is the consummation of a merger transaction with pro forma financial statements, which is a classic M&A activity event. The filing explicitly references the Merger Agreement and provides pro forma combined financial statements as if the merger had occurred on January 1, 2026/2025, confirming this is a material acquisition completion.
View raw filing on EDGAR →Onconetix implemented a 1-for-10 reverse stock split effective May 21, 2026, approved by stockholders and undertaken primarily to achieve Nasdaq minimum bid price compliance. This material capital structure event reduces outstanding shares and mitigates delisting risk.
View raw filing on EDGAR →Item 2.02 explicitly discloses financial results for the quarter ended March 31, 2026, with a press release furnished as Exhibit 99.1. This is a standard quarterly earnings announcement, which is material to investors assessing the registrant's operational performance and financial condition.
View raw filing on EDGAR →MSP Recovery entered into two material funding agreements on May 15, 2026: a $0.1 million discretionary advance from Hazel Partners under an existing working capital facility and a $0.1 million one-time advance from VRM MSP Recovery Partners to support accounts payable. These discretionary and one-time advances reflect liquidity constraints and financial stress.
View raw filing on EDGAR →MSP Recovery received notice from OTC Markets that its Class A common stock will be downgraded from the OTCQB Venture Market to the OTC Pink market effective May 20, 2026, due to failure to timely file its Form 10-K and OTCQB Annual Certification. The downgrade could adversely affect liquidity, market price, analyst coverage, and investor access.
View raw filing on EDGAR →Shareholders voted on a Charter Amendment Proposal at an Extraordinary General Meeting on April 10, 2026, approving the amendment with 3,308,619 votes in favor and 2,861,341 against. The vote resulted in 5,333,287 ordinary shares being tendered for redemption in connection with the approval.
View raw filing on EDGAR →The Company's charter was amended to extend the business combination deadline by 12 months from June 16, 2026 to June 16, 2027, following shareholder approval. The Sponsor concurrently entered into an assignment of economic interest agreement with a third party to secure votes for the amendment in exchange for transferring 50,000 Class B shares post-business combination.
View raw filing on EDGAR →The filing discloses a Board-approved proposal to add PineBridge as an additional investment sub-adviser, subject to shareholder approval at a special meeting scheduled for July 30, 2026. However, this is a pre-vote disclosure (Item 8.01, Other Events) announcing the proposal and soliciting material, not a report of actual shareholder vote results. The checkbox for "Soliciting material pursuant to Rule 14a-12" is marked, confirming this is proxy solicitation material rather than a vote outcome. The event is material as it involves a significant change to the Fund's investment strategy and sub-advisory structure, but the event_type is ambiguous—this could also be classified as "other_material" since it does not fit the shareholder_vote_results category (which reports results after voting has occurred).
View raw filing on EDGAR →The filing discloses a Board-approved change in investment sub-adviser (King Street Sub-Adviser replacing Octagon Credit Investors) that requires shareholder approval at a special meeting scheduled for July 30, 2026. While the filing is primarily a solicitation of proxies (Item 8.01, Other Events) announcing the proposed change and calling for shareholder vote, it does not yet report actual vote results. The material event is the proposed sub-adviser change and the upcoming shareholder vote, which is significant to investors in this closed-end fund.
View raw filing on EDGAR →The filing discloses a letter to stockholders regarding "the potential acquisition of certain assets and intellectual property of BullionFX Ltd." This describes entry into or contemplation of a material acquisition transaction. Although the language uses "potential," the fact that the company issued a formal stockholder letter and filed it on 8-K indicates materiality. The acquisition of assets and IP from another entity constitutes M&A activity under Item 1.01/2.01 framework, even if still in preliminary stages.
View raw filing on EDGAR →This 8-K discloses the consummation of an initial public offering (IPO) on May 18, 2026, with the registration statement declared effective on May 14, 2026. The Company raised $150 million in gross proceeds from the sale of 15 million units at $10.00 per unit, plus an additional $5.375 million from a concurrent private placement of warrants. While technically an IPO rather than a traditional M&A transaction, the filing is structured around Item 1.01 (Entry into a Material Definitive Agreement) and involves multiple material agreements (underwriting, warrant, registration rights, etc.) that constitute the foundational capital-raising event. The closest taxonomy fit is ma_activity, as this represents a material capital transaction and change of control event (transition from private to public company), though the event could also be characterized as a dilutive_issuance given the warrant components and private placement structure.
View raw filing on EDGAR →This disclosure concerns a proxy contest at Vaxart's 2026 Annual Meeting, where the Company is urging shareholders to support its six director nominees against three dissident candidates nominated by a shareholder. While proxy contests and shareholder activism can materially affect governance and strategic direction, this Item 8.01 disclosure does not fit neatly into the specific event categories (e.g., shareholder_vote_results applies to vote outcomes, not pre-vote solicitations). The disclosure is material because it signals potential control challenges and governance uncertainty, but the absence of a dedicated taxonomy category for proxy contests or shareholder activism makes "other_material" the most appropriate classification.
View raw filing on EDGAR →Shachi Singh resigned as Chief Legal Officer & General Counsel effective April 28, 2026, and Mohan Ananda resigned from the Board of Directors effective May 10, 2026. Both resignations are stated to be unrelated to disagreements with the Company.
View raw filing on EDGAR →The Company issued unregistered equity securities to settle material obligations: shares to ACM under Section 4(a)(2) and Rule 506 of Regulation D in satisfaction of a $6M judgment, and 39M shares to Reimer Plaintiffs under Section 3(a)(10) in settlement of litigation, capped at $2M value.
View raw filing on EDGAR →The Company created a direct financial obligation of $2.5M under the ACM Letter Agreement and Confession of Judgment, signaling an accelerated or triggered obligation that reflects material financial distress.
View raw filing on EDGAR →